Related Experiment Videos
Clinical experiences with trandolapril
1Department of Medicine, University Hospital Maasstricht, The Netherlands.
American Heart Journal
|May 1, 1993
Abstract:
In this article the clinical experiences with the new non-sulfhydryl angiotensin-converting enzyme inhibitor trandolapril are reviewed. The drug lowers blood pressure effectively in patients with mild-to-severe hypertension including elderly and obese patients. Distinguishing features of the compound are its long plasma half-life and high degree of lipophilicity.